Evaluation of exocrine pancreatic function in pregnant women with gestational diabetes
DOI:
https://doi.org/10.15574/HW.2024.5(174).2125Keywords:
gestational diabetes, pregnancy, exocrine pancreatic insufficiency, pancreatic enzymes, fecal elastase-1Abstract
Gestational diabetes (GD) is a consequence of physiologically determined insulin resistance in pregnant women aimed for adequate fetal growth maintenance. The frequency of GD has no tendency to decrease. Endocrine and exocrine parts of the pancreas are in anatomical and functional interaction, therefore, investigation of not only pancreatic islet but also acinar complex functioning in women with GD is becoming an urgent issue in modern pregnancy management.
Aim - to investigate the state of pancreatic exocrine function in pregnant women with GD.
Materials and methods. 104 women took part in our research. Serum levels of pancreatic lipase and amylase together with fecal elastase-1 (FE-1) concentration were evaluated. Statistically significant difference between groups was confirmed at the Student's test criterion value p≤0.05.
Results. Pregnant women with GD had significantly lower levels of serum pancreatic enzymes amylase (25.9±7.5 U/l compared to 35.1±6.8 U/l in the control group) and lipase (40.6±9.8 U/l compared to 61.9±10.5 U/l in the control group), as well as FE-1 levels (294.4±64.3 μmol/l compared to 368.1±62.1 μmol/l in the control group). A positive correlation between the level of pancreatic enzymes and the level of FE-1 was established, as well as a negative relationship between the level of FE-1 and pregnancy term.
Conclusions. GD is characterized by a decrease in pancreatic exocrine function, which worsens with increasing gestational term and can be diagnosed by measuring serum levels of amylase and lipase, as well as FE-1.
The study was conducted in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the local ethics committee of the participating institution. Informed consent was obtained from all patients.
No conflict of interests was declared by the authors.
References
Asgharnezhad M, Joukar F, Fathalipour M, Khosousi M, Hassanipour S, Pourshams A et al. (2019). Gastrointestinal symptoms in patients with diabetes mellitus and non-diabetic: A cross-sectional study in north of Iran. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 13(3): 2236-2240. https://doi.org/10.1016/j.dsx.2019.05.028; PMid:31235163
Bao L-X, Shi W-T, Han Y-X. (2021). Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine. 34(16): 2741-2753. Epub 2019 Sep 26. https://doi.org/10.1080/14767058.2019.1670804; PMid:31558075
Hardt PD, Ewald N. (2011). Exocrine Pancreatic Insufficiency in Diabetes Mellitus: A Complication of Diabetic Neuropathy or a Different Type of Diabetes? Experimental Diabetes Research. 2011: 761950. https://doi.org/10.1155/2011/761950; PMid:21822421 PMCid:PMC3148449
Hopson P, Smadi Y, Mehta V, Patel S, Mehta D, Horvath K. (2022). Assessment of exocrine pancreatic function in children and adolescents with direct and indirect testing. Frontiers in Pediatrics. 10: 908542. https://doi.org/10.3389/fped.2022.908542; PMid:36452348 PMCid:PMC9704773
Moon JH, Jang HC. (2022). Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications. Diabetes & Metabolism Journal. 46(1): 3-14. https://doi.org/10.4093/dmj.2021.0335; PMid:35135076 PMCid:PMC8831816
Nikolic, S., Maisonneuve, P., Dahlman, I., Löhr, J. M., & Vujasinovic, M. (2022). Exocrine and Endocrine Insufficiency in Autoimmune Pancreatitis: A Matter of Treatment or Time? Journal of Clinical Medicine, 11(13), 3724. https://doi.org/10.3390/jcm11133724; PMid:35807009 PMCid:PMC9267378
Philippe M-F, Benabadji S, Barbot-Trystram L, Vadrot D, Boitard C, Larger E. (2011). Pancreatic Volume and Endocrine and Exocrine Functions in Patients With Diabetes. Pancreas. 40(3): 359-363. https://doi.org/10.1097/MPA.0b013e3182072032; PMid:21283038
Piciucchi M, Capurso G, Archibugi L, Delle Fave MM, Capasso M, Delle Fave G. (2015). Exocrine Pancreatic Insufficiency in Diabetic Patients: Prevalence, Mechanisms, and Treatment. International Journal of Endocrinology. 2015: 595649. https://doi.org/10.1155/2015/595649; PMid:25892991 PMCid:PMC4393909
Singh A, Singh RK, Singh AK, Chauhan M, Gautam V. (2023). Evaluation of Serum Amylase and Lipase in Gestational Diabetes Mellitus and Association With Gastrointestinal Symptoms. Cureus. 5(11): e48376. PMID: 38060711; PMCID: PMC10698305. https://doi.org/10.7759/cureus.48376
Singh VK, Haupt ME, Geller DE, Hall JA, Diez PMQ. (2017). Less common etiologies of exocrine pancreatic insufficiency. World Journal of Gastroenterology. 23(39): 7059-7076. https://doi.org/10.3748/wjg.v23.i39.7059; PMid:29093615 PMCid:PMC5656454
Sivasarupa I, Kumarapillai S. (2021). Prevalence and associated risk factors of gestational diabetes mellitus. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 10(5): 2135. https://doi.org/10.18203/2320-1770.ijrcog20211559
Smith LIF, Bowe JE. (2021). The pancreas and the placenta: understanding gestational diabetes and why some islets fail to cope with pregnancy. The Biochemist. 43(2): 42-46. https://doi.org/10.1042/bio_2021_115
Sweeting A, Hannah W, Backman H, Catalano P, Feghali M, Herman WH et al. (2024). Epidemiology and management of gestational diabetes. The Lancet. 404(10448): 175-192. Epub 2024 Jun 20. PMID: 38909620. https://doi.org/10.1016/S0140-6736(24)00825-0; PMid:38909620
Sweeting A, Wong J, Murphy HR, Ross GP. (2022). A Clinical Update on Gestational Diabetes Mellitus. Endocrine Reviews. 43(5): 763-793. https://doi.org/10.1210/endrev/bnac003; PMid:35041752 PMCid:PMC9512153
Tanaka K, Yamada K, Matsushima M, Izawa T, Furukawa S et al. (2017). Increased maternal insulin resistance promotes placental growth and decreases placental efficiency in pregnancies with obesity and gestational diabetes mellitus. Journal of Obstetrics and Gynaecology Research. 44(1): 74-80. https://doi.org/10.1111/jog.13474; PMid:29027303
Zhu H, Chen B, Cheng Y, Zhou Y, Yan Y-S, Luo Q et al. (2019). Insulin Therapy for Gestational Diabetes Mellitus Does Not Fully Protect Offspring From Diet-Induced Metabolic Disorders. Diabetes. 68(4): 696-708. https://doi.org/10.2337/db18-1151; PMid:30696708
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ukrainian Journal Health of Woman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
